Hung Chang

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia

Hung Chang, Ming‐Chung Kuo, Lee‐Yung Shih et al. · European Journal Of Haematology · 2011 · 114 citations

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Hui‐Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung et al. · Scientific Reports · 2017 · 70 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Phase Ii Study +19

The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma

Tung‐Liang Lin, Ming‐Chung Kuo, Lee‐Yung Shih et al. · Annals of Hematology · 2012 · 52 citations

Lymphoid Neoplasia, Elderly Patients, Geriatrics +5